DAX24.423 +1,3%Est505.646 +1,2%MSCI World4.329 +0,1%Top 10 Crypto16,58 +1,7%Nas22.844 +0,4%Bitcoin103.015 +2,1%Euro1,1717 -0,1%Öl64,25 -1,8%Gold3.855 -0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
DroneShield A2DMAA Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Siemens Energy ENER6Y Tesla A1CX3T Novo Nordisk A3EU6F Plug Power A1JA81 Bayer BAY001 Alibaba A117ME HENSOLDT HAG000 Lufthansa 823212 BASF BASF11 Deutsche Telekom 555750 thyssenkrupp 750000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich kräftig im Plus -- US-Börsen schließen fester -- Tesla meldet Rekord-Auslieferungen -- BioNTech, DroneShield, Siemens Energy, Novo Nordisk, BYD, Wolfspeed, Stellantis im Fokus
Top News
September 2025: So schlugen die TecDAX-Aktien im vergangenen Monat aus September 2025: So schlugen die TecDAX-Aktien im vergangenen Monat aus
Tesla-Aktie im Fokus: Hacker deckt auf - So abgespeckt wird Teslas neuer Model Y Tesla-Aktie im Fokus: Hacker deckt auf - So abgespeckt wird Teslas neuer Model Y
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

TransMedics Group Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
98,82 EUR +1,48 EUR +1,52 %
STU
116,07 USD +1,22 USD +1,06 %
BTT
TransMedics Group jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.3,26 Mrd. EUR

KGV61,92Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PH5P

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS89377M1099

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTMDX

TransMedics Group Aktien News

DatumMeistgelesen
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Present at Upcoming March Investor Conferences
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference
PR NewswireTransMedics Reports Third Quarter 2023 Financial Results
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Third Quarter 2023 Financial Results on November 6, 2023
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
PR NewswireTransMedics Completes Acquisition of Summit Aviation
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Second Quarter 2023 Financial Results
PR NewswireBridge to Life Divests Certain Assets to TransMedics
PR NewswireBridge to Life Divests Certain Assets to TransMedics
PR NewswireTransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to Life
PR NewswireTransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
PR NewswireTransMedics Appoints Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary
PR NewswireTransMedics to Present at the Canaccord Genuity 43rd Annual Growth Conference
PR NewswireTransMedics to Report Second Quarter 2023 Financial Results on August 3, 2023
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports First Quarter 2023 Financial Results
PR NewswireTransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report
PR NewswireTransMedics to Report First Quarter 2023 Financial Results on May 1, 2023
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
PR NewswireTransMedics to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
PR NewswireTransMedics Appoints Nick Corcoran as Senior Vice President of Supply Chain and Operations
PR NewswireTransMedics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Third Quarter 2022 Financial Results
PR NewswireTransMedics to Report Third Quarter 2022 Financial Results on November 3, 2022

TransMedics Group News

TransMedics Group News: auf dieser Seite finden Sie alle TransMedics Group News und Nachrichten zur TransMedics Group Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch TransMedics Group News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um TransMedics Group News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.